Niagen Bioscience (NAGE) Other financing activities (2012 - 2025)
Niagen Bioscience (NAGE) reported Other financing activities of $55000.0 for Q4 2025, up 34.15% year-over-year from $41000.0 in Q4 2024, and up 816.67% quarter-over-quarter from $6000.0 in Q2 2025.
Niagen Bioscience (NAGE) Other financing activities (2012 - 2025) Analysis & Trends
Niagen Bioscience (NAGE) has 11 years of Other financing activities data on file, last reported at $55000.0 in Q4 2025.
- Other financing activities for Q4 2025 came in at $55000.0, up 34.15% year-over-year; the trailing twelve-month figure through Mar 2026 was $61000.0 (up 29.79% YoY), and the FY2025 annual result was $67000.0, up 28.85% from the prior year.
- Other financing activities advanced to $55000.0 in Q4 2025 per NAGE's latest filing, from $6000.0 in the prior quarter.
- Over five years, Other financing activities peaked at $75000.0 in Q4 2023 and troughed at $3000.0 in Q2 2021.
- A 5-year average of $34636.4 and a median of $41000.0 in 2024 frame the typical range for Other financing activities.
- On a YoY basis, Other financing activities climbed as much as 231.58% in 2021 and fell as far as 80.0% in 2021.
- A 5-year view of Other financing activities shows it stood at $63000.0 in 2021, then decreased by 1.59% to $62000.0 in 2022, then grew by 20.97% to $75000.0 in 2023, then slumped by 45.33% to $41000.0 in 2024, then surged by 34.15% to $55000.0 in 2025.
- Business Quant data shows NAGE's Other financing activities at $55000.0 in Q4 2025, $6000.0 in Q2 2025, and $6000.0 in Q1 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 788,338.31 Bn | 788,338.28 Bn | - |
| 2 | Belite Bio | 56,560.00 Bn | 56,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,329.30 Bn | 17,329.30 Bn | - |
| 4 | Legend Biotech | 3,341.00 Bn | 3,340.71 Bn | 242.10 Mn |
| 5 | Akari Therapeutics | 1,727.91 Bn | 1,727.91 Bn | - |
| 6 | Evaxion A | 1,536.68 Bn | 1,536.67 Bn | - |
| 7 | Psyence Biomedical | 238.34 Bn | 238.33 Bn | - |
| 8 | Vertex Pharmaceuticals | 113.42 Bn | 106.17 Bn | 2.59 Bn |
| 9 | Abivax | 95.45 Bn | 95.45 Bn | - |
| 10 | Niagen Bioscience | 280.11 Mn | 213.56 Mn | 19.98 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 55,000.00 |
| Dec 31, 2025 | 55,000.00 |
| Jun 30, 2025 | 6,000.00 |
| Jun 30, 2025 | 6,000.00 |
| Mar 31, 2025 | 6,000.00 |
| Mar 31, 2025 | 6,000.00 |
| Dec 31, 2024 | 41,000.00 |
| Dec 31, 2024 | 41,000.00 |
| Mar 31, 2024 | 11,000.00 |
| Mar 31, 2024 | 11,000.00 |
| Dec 31, 2023 | 75,000.00 |
| Dec 31, 2023 | 75,000.00 |
| Dec 31, 2022 | 62,000.00 |
| Dec 31, 2022 | 62,000.00 |
| Sep 30, 2022 | 15,000.00 |
| Sep 30, 2022 | 15,000.00 |
| Dec 31, 2021 | 63,000.00 |
| Dec 31, 2021 | 63,000.00 |
| Jun 30, 2021 | 3,000.00 |
| Jun 30, 2021 | 3,000.00 |